Christian Hogg, Hutchmed’s CEO, says the Hong Kong-based pharmaceutical firm is now “fully financed” following its homecoming listing, and explains what the company aims to do with the monies raised.
Continue reading
Christian Hogg, Hutchmed’s CEO, says the Hong Kong-based pharmaceutical firm is now “fully financed” following its homecoming listing, and explains what the company aims to do with the monies raised.
Continue reading